Methods for computational modeling to guide intratumoral therapy

US2020163642A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2020163642-A1
Application numberUS-201816637668-A
CountryUS
Kind codeA1
Filing dateAug 8, 2018
Priority dateAug 8, 2017
Publication dateMay 28, 2020
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods are presented for simulating drug movement within a model of a tumor that is mapped to the specific anatomy of the corresponding tumor in a patient as determined by imaging. With a segmentation of the tumor into distinct interconnected compartments and pre-determined initial parameters for the distributed tissue diffusivities and perfusion levels, the disclosed techniques can be used to predict the drug concentration throughout the tumor as a function of time, as well as the accumulation of drug in the rest of the body. In this way, advantageous initial parameters may be determined using the model. It is also possible to predict drug concentration throughout the tumor for a given intravenous injection of drug. Such a model serves an important role in treatment planning for lung tumors.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method for intratumoral drug treatment, comprising: obtaining an electronic image of a tumor; generating a drug distribution model based on the image, the model comprising a plurality of compartments, each compartment being classified as either a tissue compartment or a vasculature compartment based on the obtained image, and wherein each compartment has one or more adjacent compartments with a shared boundary between the compartment and each adjacent compartment; conducting one or more simulations of drug movement over time using the drug distribution model, each simulation having a set of one or more initial parameters, wherein the drug movement between each pair of adjacent compartments has a magnitude and a direction according to the classifications of the respective compartments; and determining a set of one or more advantageous initial parameters based on the one or more simulations. 2 . The method of claim 1 , wherein the magnitude and direction of drug movement between adjacent tissue compartments is based on a difference in drug concentration between each compartment, a tumor diffusivity coefficient, and a size of the shared boundary between each compartment. 3 . The method of claim 1 , wherein the magnitude and direction of drug movement between a tissue compartment and an adjacent vasculature compartment is based on a tumor diffusivity coefficient of the tissue compartment, a size of the shared boundary between the tissue compartment and the vasculature compartment, and a difference in drug concentration between the tissue compartment and the vasculature compartment. 4 . The method of claim 1 , wherein the magnitude and direction of drug movement between adjacent vascular compartments is based on a direction of blood flow and a magnitude of blood flow. 5 . The method of claim 1 , wherein each compartment of the plurality of compartments is rectangular. 6 . The method of claim 1 , wherein the image is a three-dimensional image and the drug distribution model is a three-dimensional model. 7 . The method of claim 6 , wherein the imaging is a set of images. 8 . The method of claim 7 , wherein the set of images is a set of image slices. 9 . The method of claim 8 , wherein the set of images is obtained using computed tomography. 10 . The method of claim 6 , wherein each compartment of the plurality of compartments is cuboid. 11 . The method of claim 1 , wherein the plurality of compartments are of equal size. 12 . The method of claim 1 , wherein the one or more tissue compartments are of equal size. 13 . The method of claim 1 , wherein the one or more vasculature compartments are of equal size. 14 . The method of claim 1 , wherein the set of advantageous initial parameters comprises one or more injection locations. 15 . The method of claim 14 , further comprising displaying the one or more injection locations of the set of advantageous initial parameters using a display. 16 . The method of claim 15 , wherein the one or more injection points are displayed as a heat map. 17 . The method of claim 1 , wherein the set of advantageous initial parameters comprises a drug delivery modality. 18 . The method of claim 1 , wherein the set of advantageous initial parameters comprises a drug delivery rate. 19 . The method of claim 1 , wherein the set of advantageous initial parameters comprises a drug delivery dose. 20 . The method of claim 1 , wherein the image is obtained by retrieval from an electronic storage device. 21 . The method of claim 1 , further comprising guiding one or more injections of a drug according to the advantageous set of initial parameters.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2020163642A1 cover?
Methods are presented for simulating drug movement within a model of a tumor that is mapped to the specific anatomy of the corresponding tumor in a patient as determined by imaging. With a segmentation of the tumor into distinct interconnected compartments and pre-determined initial parameters for the distributed tissue diffusivities and perfusion levels, the disclosed techniques can be used to…
Who is the assignee on this patent?
Univ Of Vermont And State Agricultural College
What technology area does this patent fall under?
Primary CPC classification A61P35/02. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu May 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).